Founded in 2013 by an ex-pharma/biotech team, MycRx is based in Melbourne, Australia, with collaborators and service providers from around the world. We have strategic partnerships with Australia's leading integrated cancer centre, the Peter MacCallum Cancer Centre (www.petermac.org), and the country's premier government research organisation, CSIRO (www.csiro.au). The company is backed by leading Australian life sciences venture capital fund the MRCF (www.mrcf.com.au), managed by Brandon Capital Partners (www.brandoncapital.com.au).